Solid Biosciences Inc. - SLDB
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 4.8% | 4,833,796 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Ryan Wilder | 4.8% | 4,833,796 | View |
| Aug 06, 2026 | SCHEDULE 13G | FMR LLC | 7.0% | 6,875,957 | View |
| Aug 06, 2026 | SCHEDULE 13G | Abigail P. Johnson | 7.0% | 6,875,957 | View |
| Jun 24, 2026 | SCHEDULE 13D/A | — | 9.99% | — | View |
| May 05, 2026 | SCHEDULE 13G/A | Invus Public Equities, L.P. | 8.7% | 8,696,431 | View |
| May 05, 2026 | SCHEDULE 13G/A | Invus Public Equities Advisors, LLC | 8.7% | 8,696,431 | View |
| May 05, 2026 | SCHEDULE 13G/A | Invus Global Management, LLC | 8.7% | 8,696,431 | View |
| May 05, 2026 | SCHEDULE 13G/A | Siren, L.L.C. | 8.7% | 8,696,431 | View |
| May 05, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master Fund LP | 1.4% | 1,370,251 | View |
| May 05, 2026 | SCHEDULE 13G/A | Avicenna Life Sci Master GP LLC | 1.4% | 1,370,251 | View |
| May 05, 2026 | SCHEDULE 13G/A | Ulys, L.L.C. | 1.4% | 1,370,251 | View |
| May 05, 2026 | SCHEDULE 13G/A | Raymond Debbane | 9.99% | 10,066,682 | View |
| Apr 27, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 4.7% | 4,578,650 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.